Back to
UBS Group AG
HRTX30 quarters
Position history for
UBS Group AG's holdings in HERON THERAPEUTICS INC
UBS Group AG holds 3M shares of HRTX (HERON THERAPEUTICS INC), worth $1.3M as of 2026-Q2. The position was increased (+31.1% shares). HRTX represents 0.0% of UBS Group AG's portfolio.
Current Value
$1.3M
Current Shares
3M
Total Value Change
-$110,250
Total Shares Change
+2.9M
Quarter-by-Quarter History
Other major holders of HRTX: FRANKLIN RESOURCES INC